3 results  1 of 1 

1 The Early Changes in Thyroid-Stimulating Immunoglobulin Bioassay over Anti-Thyroid Drug Treatment Could Predict Prognosis of Graves’ Disease
Jin Yu, Han-Sang Baek, Chaiho Jeong, Kwanhoon Jo, Jeongmin Lee, Jeonghoon Ha, Min Hee Kim, Jungmin Lee, Dong-Jun Lim
Endocrinol Metab.2023;38(3):338-346.   Published online 2023 June 9     DOI: http://dx.doi.org/10.3803/EnM.2023.1664
      
2 Clinical Implication of TSH Receptor Antibody Measurement
Dong Yeob Shin
Int J Thyroidol.2016;9(1):15-18.   Published online 2016 May 20     DOI: http://dx.doi.org/10.11106/ijt.2016.9.1.15
   
3 Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy
Young Jae Woo, Sun Young Jang, Tyler Hyung Taek Lim, Jin Sook Yoon
Korean J Ophthalmol.2015;29(4):213-219.   Published online 2015 July 21     DOI: http://dx.doi.org/10.3341/kjo.2015.29.4.213
      

 1 of 1